DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO)

CUSIP: 23725P209

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
6,768,178
Total 13F shares
1,822,496
Share change
+1,411,374
Total reported value
$29,132,627
Price per share
$16.78
Number of holders
24
Value change
+$22,411,309
Number of buys
19
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 23725P209?
CUSIP 23725P209 identifies DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Nantahala Capital Management, LLC
13F
Company
3.2%
214,091
$1,359,000 30 Jun 2020
13F
MEITAV INVESTMENT HOUSE LTD
13F
Company
1.3%
85,904
$545,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.4%
27,312
$173,000 30 Jun 2020
13F
HighTower Advisors, LLC
13F
Company
0.33%
22,224
$142,000 30 Jun 2020
13F
IPG Investment Advisors LLC
13F
Company
0.33%
22,200
$140,970 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.25%
17,100
$109,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.22%
15,145
$96,000 30 Jun 2020
13F
UBS Group AG
13F
Company
0.04%
2,860
$18,000 30 Jun 2020
13F
SIGNATUREFD, LLC
13F
Company
0.02%
1,462
$9,000 30 Jun 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
1,372
$9,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
500
$3,000 30 Jun 2020
13F
HARBOR INVESTMENT ADVISORY, LLC
13F
Company
0.01%
475
$3,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0%
300
$2,000 30 Jun 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
177
$1,000 30 Jun 2020
13F

Institutional Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) as of Q3 2020

As of 30 Sep 2020, DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,822,496 shares. The largest 10 holders included Phoenix Holdings Ltd., Nantahala Capital Management, LLC, FRIESS ASSOCIATES LLC, VANGUARD GROUP INC, MEITAV DASH INVESTMENTS LTD, DRIEHAUS CAPITAL MANAGEMENT LLC, ROYAL BANK OF CANADA, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and IPG Investment Advisors LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
14
Q3 2020 holders
24
Holder diff
10
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .